Table 2 Other coagulation parameters at baseline
From: Enoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trial
Parameter | Enoxaparin 40 mg | Enoxaparin 50 mg | Enoxaparin 60 mg | Enoxaparin 70 mg | p |
|---|---|---|---|---|---|
TAT (μg/L) | 8 (6-16) | 10 (5-15) | 13 (7-25) | 11 (6-19) | 0.5 |
aPTT (seconds) | 41 (36-49) | 44 (36-47) | 40 (37-46) | 43 (39-49) | 0.9 |
PT (%) | 73 (43-81) | 73 (56-82) | 60 (54-88) | 67 (52-77) | 1.0 |
Platelets (×109/L) | 211 (147-356) | 220 (165-278) | 201 (137-283) | 299 (200-394) | 0.4 |
AT (%) | 77 (48-99) | 72 (40-109) | 72 (45-105) | 82 (65-99) | 0.9 |
Fibrinogen (μmol/L) | 15 (13-18) | 16 (12-18) | 16 (13-19) | 15 (11-21) | 1.0 |
Ddimer (mg/L) | 2 (2-5) | 4 (2-5) | 3 (2-4) | 3 (2-5) | 0.5 |